Increase in serum creatinine levels after PARP inhibitor treatment

Di Youa Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China;b Ministry of Education, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Chengdu, ChinaView further author information

Lan Zhonga Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China;b Ministry of Education, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Chengdu, ChinaView further author information

Rutie Yina Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China;b Ministry of Education, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Chengdu, ChinaView further author information

Liang Songa Department of Obstetrics and Gynecology, West China Second University Hospital, Sichuan University, Chengdu, China;b Ministry of Education, Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Chengdu, ChinaCorrespondence[email protected]
View further author information

Click to increase image sizeClick to decrease image size

Ethics approval and consent to participate

This study was approved by the Ethics Committee of West China Second University Hospital of Sichuan University, and the patient provided written informed consent.

Consent for publication

Written informed consent to publish the case report was obtained from the patient.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by the Horizontal Topic of Sichuan University under Grant numbers 22H0226 and 22H0851.

Increase in serum creatinine levels after PARP inhibitor treatment

Information for

Open access

Opportunities

Help and information

Increase in serum creatinine levels after PARP inhibitor treatment

Ethics approval and consent to participate

Consent for publication

Disclosure statement

Additional information

Funding

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature